Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Genmark Diagnostics Inc's Business Segments
Genmark Diagnostics Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
-
Annual Results
Revenue by Product & Service Category -
- ePlex Revenue88.9%
- XT-8 Revenue9.7%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| ePlex Revenue | $ 153 | 88.9% |
| XT-8 Revenue | $ 17 | 9.7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Genmark Diagnostics Inc
GenMark Diagnostics Inc. is a leading molecular diagnostics company that develops and commercializes high-accuracy, easy-to-use multiplex molecular tests that detects infectious diseases, genetic conditions as well as cancer. The company is headquartered in Carlsbad, California, and it was founded in 2010.
The company specializes in developing molecular diagnostic solutions that use its proprietary eSensor® detection technology, which is a microelectronic sensor that can detect and identify multiple genetic targets within a single sample. This technology provides highly accurate, actionable results that can guide physicians in making informed patient care decisions.
GenMark Diagnostics' products are used in hospitals, reference labs, and specialty clinics. The company's flagship product is the ePlex® system, which is a fully integrated, automated, and scalable multiplex system that can detect up to 24 analytes from a single patient sample. The ePlex® system can process samples in less than 2 hours and has a high degree of accuracy, which makes it an industry-leading offering.
In addition to its ePlex® system, GenMark Diagnostics also offers a range of other products, including the eSensor® XT-8 and the XT-8 systems. These products are designed for use in infectious disease testing, genetic testing, and oncology testing.
GenMark Diagnostics' team of experienced professionals includes scientists, engineers, and sales and marketing experts who bring deep expertise in developing and commercializing advanced molecular diagnostic solutions. The company has partnerships with leading healthcare organizations, reference labs, and industry organizations that help it to build a strong presence in the market.
Overall, GenMark Diagnostics is known for developing innovative, high-accuracy, and easy-to-use diagnostic solutions that help clinicians to diagnose and treat infectious diseases, genetic conditions, and cancer. The company's advanced eSensor® technology and its range of proprietary products have made it a leader in the molecular diagnostics market.
The company specializes in developing molecular diagnostic solutions that use its proprietary eSensor® detection technology, which is a microelectronic sensor that can detect and identify multiple genetic targets within a single sample. This technology provides highly accurate, actionable results that can guide physicians in making informed patient care decisions.
GenMark Diagnostics' products are used in hospitals, reference labs, and specialty clinics. The company's flagship product is the ePlex® system, which is a fully integrated, automated, and scalable multiplex system that can detect up to 24 analytes from a single patient sample. The ePlex® system can process samples in less than 2 hours and has a high degree of accuracy, which makes it an industry-leading offering.
In addition to its ePlex® system, GenMark Diagnostics also offers a range of other products, including the eSensor® XT-8 and the XT-8 systems. These products are designed for use in infectious disease testing, genetic testing, and oncology testing.
GenMark Diagnostics' team of experienced professionals includes scientists, engineers, and sales and marketing experts who bring deep expertise in developing and commercializing advanced molecular diagnostic solutions. The company has partnerships with leading healthcare organizations, reference labs, and industry organizations that help it to build a strong presence in the market.
Overall, GenMark Diagnostics is known for developing innovative, high-accuracy, and easy-to-use diagnostic solutions that help clinicians to diagnose and treat infectious diseases, genetic conditions, and cancer. The company's advanced eSensor® technology and its range of proprietary products have made it a leader in the molecular diagnostics market.
Genmark Diagnostics Inc Overview
Genmark Diagnostics Inc is a recognized leader in the field of molecular diagnostics, providing innovative solutions designed to meet the diverse needs of healthcare settings, including clinical laboratories, hospitals, and various healthcare providers. Their commitment to advancing the diagnosis of infectious diseases and other critical health conditions is demonstrated through an extensive portfolio of segments, products, and services.
Segments
Genmark Diagnostics operates across several key segments:
1. Respiratory Testing:
This segment specializes in diagnostic tests aimed at identifying respiratory infections. By utilizing advanced molecular technologies, Genmarks respiratory testing solutions can swiftly deliver accurate results, enabling clinicians to make timely decisions for patient care. Key products in this segment include:
- ePlex Respiratory Pathogen Panel: A comprehensive panel capable of detecting multiple respiratory pathogens, supporting rapid diagnosis and management of respiratory illnesses.
- ePlex RP2 Panel: An extension of the respiratory testing capabilities that focuses on an expanded array of respiratory conditions.
2. Blood Culture Identification:
In the fight against bloodstream infections, Genmark Diagnostics provides vital tools that help in the identification of pathogens present in blood cultures. Key offerings under this segment include:
- ePlex BCID Blood Culture Identification Panel: This robust panel enables clinicians to identify a broad spectrum of bacterial and fungal pathogens directly from blood cultures, significantly reducing turnaround time for critical clinical decisions.
3. Gastrointestinal Testing:
The gastrointestinal testing segment is dedicated to identifying infectious agents that cause gastrointestinal diseases. Genmark’s solutions in this area include:
- ePlex Gastrointestinal Pathogen Panel: A detailed testing panel that helps in the detection of various gastrointestinal pathogens, providing essential data for the effective treatment of gastrointestinal disorders.
4. Sexually Transmitted Infection Testing:
Addressing the critical area of sexually transmitted infections (STIs), Genmark offers tests that provide accurate and timely results on a range of STIs, including:
- ePlex STI 1 Panel: This panel aids in the detection of multiple sexually transmitted pathogens, facilitating comprehensive management of patients sexual health.
5. Other Testing:
This diverse segment encompasses a range of tests aimed at identifying various diseases and conditions beyond the primary areas of focus. Notable tests include:
- ePlex SARS-CoV-2 Test: Developed to detect the presence of the SARS-CoV-2 virus responsible for COVID-19, this test underscores Genmarks adaptability to emerging global health challenges.
- ePlex AMR Panel: This tests for antibiotic resistance, providing critical information for the selection of appropriate therapies conducive to patient outcomes.
Products
Genmark Diagnostics product lineup showcases a range of innovative diagnostic solutions:
1. ePlex System:
A fully automated molecular diagnostic testing platform, the ePlex System is designed to provide rapid and accurate results across a wide spectrum of infections while streamlining laboratory workflows and enhancing operational efficiency.
2. eSensor XT-8:
This nucleic acid testing platform supports multiplexed detection capabilities, enabling simultaneous testing for multiple pathogens or genetic markers, which enhances diagnostic accuracy.
3. ePlex Panels:
A series of specialized testing panels, including:
- ePlex Respiratory Pathogen Panel
- ePlex BCID Blood Culture Identification Panel
- ePlex Gastrointestinal Pathogen Panel
- ePlex STI 1 Panel
- ePlex SARS-CoV-2 Test
Each panel is designed with a focus on rapidity, reliability, and comprehensive detection capabilities in various infection contexts.
Services
In addition to its robust product offerings, Genmark Diagnostics Inc provides a suite of services designed to support their customers and enhance the effectiveness of their diagnostic solutions:
1. Customer Support:
Genmark offers dedicated customer support services to assist healthcare providers with product inquiries, troubleshooting, and other concerns, ensuring a seamless user experience.
2. Training:
Comprehensive training programs are available for healthcare providers and laboratory personnel to promote optimal use of Genmark’s products, ensuring a thorough understanding of their functionalities.
3. Maintenance:
Regular maintenance services are provided to ensure the ePlex System and other platforms operate at peak performance, minimizing downtime and ensuring consistent reliability in diagnostic results.
4. Installation:
Genmarks installation services ensure that their diagnostic systems are properly integrated into existing laboratory infrastructures, facilitating a smooth transition and helping to maximize the impact of their technologies.
In summary, Genmark Diagnostics Inc stands out in the molecular diagnostics landscape with a broad spectrum of innovative products and dedicated services aimed at enhancing patient care within the healthcare sector. Their expertise in various infectious disease testing segments reflects their commitment to addressing critical health challenges through advanced diagnostic technologies.
Genmark Diagnostics Inc is a recognized leader in the field of molecular diagnostics, providing innovative solutions designed to meet the diverse needs of healthcare settings, including clinical laboratories, hospitals, and various healthcare providers. Their commitment to advancing the diagnosis of infectious diseases and other critical health conditions is demonstrated through an extensive portfolio of segments, products, and services.
Segments
Genmark Diagnostics operates across several key segments:
1. Respiratory Testing:
This segment specializes in diagnostic tests aimed at identifying respiratory infections. By utilizing advanced molecular technologies, Genmarks respiratory testing solutions can swiftly deliver accurate results, enabling clinicians to make timely decisions for patient care. Key products in this segment include:
- ePlex Respiratory Pathogen Panel: A comprehensive panel capable of detecting multiple respiratory pathogens, supporting rapid diagnosis and management of respiratory illnesses.
- ePlex RP2 Panel: An extension of the respiratory testing capabilities that focuses on an expanded array of respiratory conditions.
2. Blood Culture Identification:
In the fight against bloodstream infections, Genmark Diagnostics provides vital tools that help in the identification of pathogens present in blood cultures. Key offerings under this segment include:
- ePlex BCID Blood Culture Identification Panel: This robust panel enables clinicians to identify a broad spectrum of bacterial and fungal pathogens directly from blood cultures, significantly reducing turnaround time for critical clinical decisions.
3. Gastrointestinal Testing:
The gastrointestinal testing segment is dedicated to identifying infectious agents that cause gastrointestinal diseases. Genmark’s solutions in this area include:
- ePlex Gastrointestinal Pathogen Panel: A detailed testing panel that helps in the detection of various gastrointestinal pathogens, providing essential data for the effective treatment of gastrointestinal disorders.
4. Sexually Transmitted Infection Testing:
Addressing the critical area of sexually transmitted infections (STIs), Genmark offers tests that provide accurate and timely results on a range of STIs, including:
- ePlex STI 1 Panel: This panel aids in the detection of multiple sexually transmitted pathogens, facilitating comprehensive management of patients sexual health.
5. Other Testing:
This diverse segment encompasses a range of tests aimed at identifying various diseases and conditions beyond the primary areas of focus. Notable tests include:
- ePlex SARS-CoV-2 Test: Developed to detect the presence of the SARS-CoV-2 virus responsible for COVID-19, this test underscores Genmarks adaptability to emerging global health challenges.
- ePlex AMR Panel: This tests for antibiotic resistance, providing critical information for the selection of appropriate therapies conducive to patient outcomes.
Products
Genmark Diagnostics product lineup showcases a range of innovative diagnostic solutions:
1. ePlex System:
A fully automated molecular diagnostic testing platform, the ePlex System is designed to provide rapid and accurate results across a wide spectrum of infections while streamlining laboratory workflows and enhancing operational efficiency.
2. eSensor XT-8:
This nucleic acid testing platform supports multiplexed detection capabilities, enabling simultaneous testing for multiple pathogens or genetic markers, which enhances diagnostic accuracy.
3. ePlex Panels:
A series of specialized testing panels, including:
- ePlex Respiratory Pathogen Panel
- ePlex BCID Blood Culture Identification Panel
- ePlex Gastrointestinal Pathogen Panel
- ePlex STI 1 Panel
- ePlex SARS-CoV-2 Test
Each panel is designed with a focus on rapidity, reliability, and comprehensive detection capabilities in various infection contexts.
Services
In addition to its robust product offerings, Genmark Diagnostics Inc provides a suite of services designed to support their customers and enhance the effectiveness of their diagnostic solutions:
1. Customer Support:
Genmark offers dedicated customer support services to assist healthcare providers with product inquiries, troubleshooting, and other concerns, ensuring a seamless user experience.
2. Training:
Comprehensive training programs are available for healthcare providers and laboratory personnel to promote optimal use of Genmark’s products, ensuring a thorough understanding of their functionalities.
3. Maintenance:
Regular maintenance services are provided to ensure the ePlex System and other platforms operate at peak performance, minimizing downtime and ensuring consistent reliability in diagnostic results.
4. Installation:
Genmarks installation services ensure that their diagnostic systems are properly integrated into existing laboratory infrastructures, facilitating a smooth transition and helping to maximize the impact of their technologies.
In summary, Genmark Diagnostics Inc stands out in the molecular diagnostics landscape with a broad spectrum of innovative products and dedicated services aimed at enhancing patient care within the healthcare sector. Their expertise in various infectious disease testing segments reflects their commitment to addressing critical health challenges through advanced diagnostic technologies.